BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients. BMJ Open 2019;9:e024908. [PMID: 30975673 DOI: 10.1136/bmjopen-2018-024908] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Bloom RD, Augustine JJ. Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34362810 DOI: 10.2215/CJN.14840920] [Reference Citation Analysis]
2 Arnau A, Benito-Hernández A, Ramos-Barrón MA, García-Unzueta MT, Gómez-Román JJ, Gómez-Ortega JM, López-Hoyos M, San Segundo D, Ruiz JC, Rodrigo E. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage. Ann Transplant 2021;26:e929491. [PMID: 33686050 DOI: 10.12659/AOT.929491] [Reference Citation Analysis]
3 Rush DN. Subclinical Rejection: a Universally Held Concept? Curr Transpl Rep 2020;7:163-8. [DOI: 10.1007/s40472-020-00290-2] [Reference Citation Analysis]
4 Handschin J, Hirt-Minkowski P, Hönger G, Mitrovic S, Savic Prince S, Ho J, Nickerson P, Schaub S. Technical Considerations and Confounders for Urine CXCL10 Chemokine Measurement. Transplant Direct 2020;6:e519. [PMID: 32047847 DOI: 10.1097/TXD.0000000000000959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
5 Lubetzky ML, Salinas T, Schwartz JE, Suthanthiran M. Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status. Clin J Am Soc Nephrol 2021:CJN. [PMID: 33906907 DOI: 10.2215/CJN.14010820] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]